Mogensen F, Knudsen J B, Rasmussen V, Kjøller E, Gormsen J
Thromb Res. 1985 Jan 15;37(2):259-66. doi: 10.1016/0049-3848(85)90014-3.
14 patients with effort induced angina pectoris were treated with a specific TxB2 inhibitor Dazoxiben or verapamil for two weeks with a wash-out period of 14 days between the two regimens. A sub-maximal bicycle test was performed before treatment and at the end of each treatment period. The bicycle test induced a significant increase in serum TxB2 in patients without treatment and during verapamil therapy. This increase was significantly inhibited by Dazoxiben treatment. No alterations in plasma TxB2 or 6-keto-PGF1 alpha were observed on either regimen. Dazoxiben had no clinical effect, while verapamil caused a highly significant prolongation of exercise time.
14例劳力性心绞痛患者接受了特异性血栓素B2(TxB2)抑制剂达唑氧苯或维拉帕米治疗,为期两周,两种治疗方案之间有14天的洗脱期。在治疗前以及每个治疗期结束时进行次极量自行车试验。自行车试验在未治疗患者以及接受维拉帕米治疗期间导致血清TxB2显著升高。达唑氧苯治疗可显著抑制这种升高。两种治疗方案均未观察到血浆TxB2或6-酮-前列环素F1α(6-keto-PGF1α)有改变。达唑氧苯无临床效果,而维拉帕米使运动时间显著延长。